Alphatec Spine Appoints New Vice President of Clinical, Quality and Regulatory
04 Mai 2010 - 2:00PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, announced today that Michael J.
Sarrasin, who has over 20 years of clinical, quality assurance and
regulatory affairs experience in the medical device and life
sciences industries, has been named the Company's Vice President,
Clinical, Quality and Regulatory.
In this newly created position Mr. Sarrasin will be responsible
for providing overall strategic direction and leadership to
Alphatec Spine's global clinical, quality assurance and regulatory
affairs groups.
Most recently, Mr. Sarrasin served as Vice President, Regulatory
Affairs and Quality Assurance for I-Flow Incorporated, a Lake
Forest, CA-based medical device infusion pump manufacturer.
In that position, he was responsible for formulating and
implementing all of I-Flow's regulatory and quality assurance
strategies and programs.
Prior to joining I-Flow, Mr. Sarrasin served in vice-president
level positions at several other medical device and life science
companies, including Celerus Diagnostics Incorporated, DAKO USA
Incorporated and LySonix Incorporated.
"We are pleased to have Mike Sarrasin join our management team
and we feel as though he will be a tremendous asset for Alphatec
Spine," said Dirk Kuyper, the Company's President and CEO.
"He has over two decades of experience in the medical device and
life science industries, and has led clinical, quality assurance
and regulatory affairs departments for several successful
companies. We believe that Mike's expertise will provide us
with the necessary leadership in an environment in which the path
to regulatory approval for products seems to be becoming less
predictable, especially as we continue to bring our novel and
innovative products to both the U.S. and international spine
market."
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical
device company that designs, develops, manufactures and markets
products for the surgical treatment of spine disorders, primarily
focused on the aging spine. The Company's mission is to
combine world-class customer service with innovative,
surgeon-driven design that will help improve the aging patient's
quality of life. The Company is poised to achieve its goal
through new solutions for patients with osteoporosis, stenosis and
other aging spine deformities, improved minimally invasive products
and techniques and integrated biologics solutions. In
addition to its U.S. operations, the Company also markets its
products in over 50 international markets through its subsidiary,
Scient'x S.A., via a direct salesforce in France, Italy and the
United Kingdom and via independent distributors in the rest of
Europe, the Middle East and Africa, South America and Latin
America. In Asia and Australia, the Company markets its
products through its subsidiary, Alphatec Pacific, Inc, and through
Scient'x's distributors in China, Korea and Australia.
The Alphatec Holdings, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3520
CONTACT: Alphatec Spine, Inc.
Peter C. Wulf, Chief Financial Officer
(760) 494-6746
investorrelations@alphatecspine.com
Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024